Found 4 matching trials
Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients PHASE2 This study was to compare CFZ533 to tacrolimus (TAC) in prevention of organ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's Syndrome PHASE2 This study did evaluate the safety,tolerability and preliminary therapeutic...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Study the Efficacy and Safety of VAY736 and CFZ533 in SLE Patients PHASE2 This study is designed to evaluate the safety, tolerability, pharmacokineti...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren's Syndrome PHASE2 This study was to evaluate the safety, efficacy, pharmacokinetics (PK) and ...
Show More Location
North GA Rheumatology Group PC
Learn More & Join Trial